Operating Margin of SAB Biotherapeutics, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
SAB Biotherapeutics, Inc. annual and quarterly Operating Margin in % history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • SAB Biotherapeutics, Inc. Operating Margin for the quarter ending 30 Jun 2024 was -1647%, a 258% decline year-over-year.
  • SAB Biotherapeutics, Inc. annual Operating Margin for 2024 was -3245%, a 91% decline from 2023.
  • SAB Biotherapeutics, Inc. annual Operating Margin for 2023 was -1701%, a 1306% decline from 2022.
  • SAB Biotherapeutics, Inc. annual Operating Margin for 2022 was -121%, a 450% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)

SAB Biotherapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -3245% -1544% -91% 01 Jan 2024 31 Dec 2024
2023 -1701% -1580% -1306% 01 Jan 2023 31 Dec 2023
2022 -121% -99% -450% 01 Jan 2022 31 Dec 2022
2021 -22% -59% -159% 01 Jan 2021 31 Dec 2021
2020 37% 01 Jan 2020 31 Dec 2020

SAB Biotherapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -1647% -1187% -258% 01 Apr 2024 30 Jun 2024
Q1 2024 -1616% -1383% -592% 01 Jan 2024 31 Mar 2024
Q4 2023 -1701% -1580% -1306% 01 Oct 2023 31 Dec 2023
Q3 2023 -661% -574% -663% 01 Jul 2023 30 Sep 2023
Q2 2023 -460% -404% -722% 01 Apr 2023 30 Jun 2023
Q1 2023 -233% -196% -522% 01 Jan 2023 31 Mar 2023
Q4 2022 -121% -99% -450% 01 Oct 2022 31 Dec 2022
Q3 2022 -87% 01 Jul 2022 30 Sep 2022
Q2 2022 -56% 01 Apr 2022 30 Jun 2022
Q1 2022 -38% 01 Jan 2022 31 Mar 2022
Q4 2021 -22% 01 Oct 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.